Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators.

Sadarmin PP, Wong KC, Rajappan K, Bashir Y, Betts TR.

Europace. 2014 Nov;16(11):1575-9. doi: 10.1093/europace/euu054. Epub 2014 Mar 25.

PMID:
24668515
2.
3.

Prolongation of the QTc interval predicts appropriate implantable cardioverter-defibrillator therapies in hypertrophic cardiomyopathy.

Gray B, Ingles J, Medi C, Semsarian C.

JACC Heart Fail. 2013 Apr;1(2):149-55. doi: 10.1016/j.jchf.2013.01.004. Epub 2013 Apr 1.

PMID:
24621839
4.

The Brugada syndrome revisited.

Mashar M, Kwok AJ, Pinder R, Sabir I.

Trends Cardiovasc Med. 2014 Jul;24(5):191-6. doi: 10.1016/j.tcm.2013.11.001. Epub 2013 Nov 11. Review.

PMID:
24332084
5.

Can we predict sudden cardiac death in long-term survivors of atrial switch surgery for transposition of the great arteries?

Wheeler M, Grigg L, Zentner D.

Congenit Heart Dis. 2014 Jul-Aug;9(4):326-32. doi: 10.1111/chd.12145. Epub 2013 Oct 23.

PMID:
24151816
6.

Hot topics in tetralogy of Fallot.

Villafañe J, Feinstein JA, Jenkins KJ, Vincent RN, Walsh EP, Dubin AM, Geva T, Towbin JA, Cohen MS, Fraser C, Dearani J, Rosenthal D, Kaufman B, Graham TP Jr; Adult Congenital and Pediatric Cardiology Section, American College of Cardiology.

J Am Coll Cardiol. 2013 Dec 10;62(23):2155-66. doi: 10.1016/j.jacc.2013.07.100. Epub 2013 Sep 27.

7.

CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.

Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, Tokuda M, Daly CA, Tedrow UB, Stevenson WG, Jerosch-Herold M, Ghoshhajra BB, Kwong RY.

JACC Cardiovasc Imaging. 2013 Sep;6(9):944-54. doi: 10.1016/j.jcmg.2013.05.013. Epub 2013 Aug 8.

8.

Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.

Griksaitis MJ, Rosengarten JA, Gnanapragasam JP, Haw MP, Morgan JM.

Europace. 2013 Apr;15(4):523-30. doi: 10.1093/europace/eus388. Epub 2013 Jan 20.

9.

The subcutaneous implantable cardioverter-defibrillator: should patients want one?

Hauser RG.

J Am Coll Cardiol. 2013 Jan 8;61(1):20-2. doi: 10.1016/j.jacc.2012.07.069. Epub 2012 Nov 1.

10.

[Totally subcutaneous defibrillator].

Valero E, Pesce R.

Arch Cardiol Mex. 2012 Jul-Sep;82(3):230-4. doi: 10.1016/j.acmx.2012.06.004. Epub 2012 Sep 14. Review. Spanish.

PMID:
23021360
11.

Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failure.

Blanco RR, Austin H, Vest RN 3rd, Valadri R, Li W, Lassegue B, Song Q, London B, Dudley SC, Bloom HL, Searles CD, Zafari AM.

J Card Fail. 2012 Sep;18(9):717-23. doi: 10.1016/j.cardfail.2012.06.531. Epub 2012 Aug 9.

12.

Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant.

Brignole M, Occhetta E, Bongiorni MG, Proclemer A, Favale S, Iacopino S, Calò L, Vado A, Buja G, Mascioli G, Quartieri F, Tritto M, Parravicini U, Castro A, Tomasi C, Villani GQ, D'Acri MG, Klersy C, Gasparini M; SAFE-ICD Study Investigators.

J Am Coll Cardiol. 2012 Sep 11;60(11):981-7. doi: 10.1016/j.jacc.2012.05.014. Epub 2012 Aug 1.

13.

Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia.

Matsue Y, Suzuki M, Nishizaki M, Hojo R, Hashimoto Y, Sakurada H.

J Am Coll Cardiol. 2012 Sep 4;60(10):908-13. doi: 10.1016/j.jacc.2012.03.070. Epub 2012 Jul 25.

14.

Implantable cardioverter-defibrillator insertion in congenital heart disease without transvenous access to the heart.

Nery PB, Green MS, Khairy P, Alhebaishi Y, Hendry P, Birnie DH.

Can J Cardiol. 2013 Feb;29(2):254.e1-3. doi: 10.1016/j.cjca.2012.04.020. Epub 2012 Jun 30.

PMID:
22749646
15.

Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.

Sredniawa B, Kowalczyk J, Lenarczyk R, Kowalski O, Sędkowska A, Cebula S, Musialik-Łydka A, Kalarus Z.

Kardiol Pol. 2012;70(5):447-55.

16.

The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated.

Caldwell J, Moreton N, Khan N, Kerzin-Storrar L, Metcalfe K, Newman W, Garratt CJ.

Heart. 2012 Apr;98(8):631-6. doi: 10.1136/heartjnl-2011-300924.

PMID:
22505462
17.

Implantation of a completely subcutaneous ICD system: case report of a patient with Brugada syndrome and state of the art.

De Maria E, Bonetti L, Patrizi G, Scrivener J, Andraghetti A, Di Gregorio F, Montin A, Zuccon G, Cappelli S.

J Interv Card Electrophysiol. 2012 Jun;34(1):105-13. doi: 10.1007/s10840-011-9626-5. Epub 2011 Oct 13. Review.

PMID:
21993598
18.

Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.

Gravelin LM, Yuhas J, Remetz M, Radford M, Foley J, Lampert R.

Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):152-6. doi: 10.1161/CIRCOUTCOMES.110.956987. Epub 2011 Feb 8.

19.

Implantable cardioverter defibrillator therapy: a single center experience in saudi arabia.

Hersi AS.

Open Cardiovasc Med J. 2010 Sep 28;4:192-7. doi: 10.2174/1874192401004010192.

20.

Clinical and psychological impact of prophylactic implantable cardioverter-defibrillators in a community heart failure population.

Arnous S, Murphy NF, Pyne-Daly P, Nawoor Z, Keane D, Ledwidge M, McDonald K.

Ir J Med Sci. 2011 Jun;180(2):369-74. doi: 10.1007/s11845-010-0659-z. Epub 2010 Dec 14.

PMID:
21153928
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk